Clinical trial
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli…
NCT01597973 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT01597973 |
|---|---|
| Title | Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) |
| Official title | Randomized Controlled Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia, Blood Stream Infection |
| Intervention type | Drug |
| Interventions | colistin and meropenem, colistin and placebo |
| Enrollment | 467 |
| Start date | Oct 6, 2012 |
| Primary completion | Aug 9, 2020 |
| Completion | Aug 9, 2020 |
| First posted | May 15, 2012 |
| Last update posted | Nov 14, 2022 |
| Countries | Bulgaria, Greece, Israel, Italy, Taiwan, Thailand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: